MiNK Therapeutics, Inc. (INKT)
NASDAQ (CM) NASDAQ (CM) Primary 
MiNK Therapeutics, Inc. (INKT) Q3 2025 Earnings Call Transcript
MiNK Therapeutics, Inc. ( INKT ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Stefanie Perna-Nacar Jennifer Buell - President, CEO & Director Terese Hammond - Head of Inflammatory & Pulmonary Diseases Christine Klaskin - Treasurer and Principal Financial & Accounting Officer Conference Call Participants Emily Bodnar - H.C. Wainwright & Co, LLC, Research Division Mayank Mamtani - B.
MiNK Therapeutics, Inc. (INKT) Q2 2025 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Christine M. Klaskin - Treasurer and Principal Financial & Accounting Officer Jennifer S.
MiNK Therapeutics, Inc. (INKT) Q1 2025 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT ) Q1 2025 Earnings Conference Call May 15, 2025 8:30 AM ET Company Participants Zack Armen - IR Jennifer Buell - President and CEO Christine Klaskin - Principal Financial and Accounting Officer Thiago Favano - Senior Director, Portfolio Operations Conference Call Participants Emily Bodnar - H.C. Wainwright Matt Phipps - William Blair Operator Thank you for standing by.
MiNK Therapeutics, Inc. (INKT) Q4 2024 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT ) Q4 2024 Earnings Conference Call March 18, 2025 8:30 AM ET Company Participants Zack Armen - Investor Relations Dr. Jennifer Buell - President and CEO Christine Klaskin - Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar - H.C. Wainwright Mayank Mamtani - B.
MiNK Therapeutics, Inc. (INKT) Q3 2024 Earnings Conference Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT ) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Alexa Buffa - Corporate Communications Jennifer Buell - President and Chief Executive Officer Christine Klaskin - Principal Financial and Accounting Officer Paul Ibbett - Scientist Conference Call Participants Emily Bodnar - H.C. Wainwright Operator Thank you for standing by.
MiNK Therapeutics, Inc. (INKT) Q2 2024 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Zack Armen - Head, Investor Relations Jennifer Buell - President and Chief Executive Officer Marc Van Dijk - Chief Scientific Officer Christine Klaskin - Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar - H.C. Wainwright Jack Allen - Baird Mayank Mamtani - B.
MiNK Therapeutics, Inc. (INKT) Upgraded to Strong Buy: Here's What You Should Know
MiNK Therapeutics, Inc. (INKT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
